AmerisourceBergen (ABC) was downgraded to market perform at Leerink Partners. $75 price target. The company will continue to face significant earnings risk into 2017, Leerink said.
Akorn (AKRX) was downgraded to sector perform at RBC Capital. $24 price target. The company lacks near-term visibility, RBC said.
Brown & Brown (BRO) was downgraded to underperform at BMO Capital. $37 price target. Margin contraction is weighing on earnings growth, BMO said.
Consolidated Communications (CNSL) was upgraded to buy at Drexel Hamilton. $26 price target. The stock has been weak following a strong quarter and the company offers an attractive 7% yield, Drexel said.
Cornerstone OnDemand (CSOD) was downgraded to underweight from neutral at JPMorgan. $25 price target. Revenue guidance will likely disappoint, given a shift in buyer habits, JPMorgan said.
Cornerstone OnDemand was also downgraded at Credit Suisse, to neutral from outperform. $35 price target. Earnings estimates were also cut, given the company's new guidance, Credit Suisse said.
Express Scripts (ESRX) was upgraded to hold from sell at Deutsche Bank. The valuation is more attractive, based on a $70 price target, Deutsche said.
Fluor (FLR) was downgraded to neutral from buy at DA Davidson. $52 price target. Higher project charges led to sharp earnings shortfall, Davidson said.
FMC (FMC) was upgraded to outperform from neutral at Credit Suisse. $57 price target. Earnings estimates were also increased, given lithium growth, Credit Suisse said.
Imperva (IMPV) was upgraded to buy from neutral at DA Davidson. The valuation is more attractive, based on a $57 price target, Davidson said.
Lions Gate (LGF) was upgraded to outperform at RBC Capital. $31 price target. The market is not factoring in cash synergies from the Starz acquisition, RBC said.
Microchip (MCHP) was upgraded to neutral from sell at Goldman Sachs. $57 price target. Near-term data points are improving, Goldman said.
Marsh & McLennan (MMC) was upgraded to outperform at BMO Capital. $76 price target. The recent pullback has created a buying opportunity, BMO said.
Insulet (PODD) was upgraded to buy at BTIG. $42 price target. Management is executing a turnaround and business is booming, BTIG said.
Qorvo (QRVO) was downgraded to underperform from buy at Bank of America/Merrill Lynch. $50 price target. The company is facing margin issues and seasonal headwinds, analysts said.
TreeHouse Foods (THS) was downgraded to underperform from buy at Bank of America/Merrill Lynch. $67 price target. Guidance was cut, because of a weaker operating outlook, analysts said.
VWR (VWR) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $28 price target. Organic growth is moderating and the company lacks catalysts, analysts said.
Whole Foods (WFM) was downgraded to underperform from neutral at Bank of America/Merrill Lynch. $25 price target. Customer traffic declines are accelerating, analysts said.